“Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes from Two Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1 and CIMPASI-2)”. SKIN The Journal of Cutaneous Medicine 1, no. 3.1 (October 27, 2017): s4. Accessed April 20, 2026. https://skin.dermsquared.com/skin/article/view/126.